HQY rides on strong HSA growth, AI-driven efficiency gains and solid Q3 results, though data security threats remain a key risk.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Shares of HealthEquity, Inc. (NASDAQ: HQY - Get Free Report) have earned an average rating of "Moderate Buy" from the seventeen research firms that are covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation, twelve have issued a buy recommendation and two have given a strong buy recommendation to the

HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.

HealthEquity (HQY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

HQY stock gains post Q3 results as earnings and revenue top estimates, supported by rising HSAs and stronger margins.

HealthEquity, Inc. (HQY) Q3 2026 Earnings Call Transcript

The headline numbers for HealthEquity (HQY) give insight into how the company performed in the quarter ended October 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

HealthEquity (HQY) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.9 per share. This compares to earnings of $0.78 per share a year ago.